NCT00088088: STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) |
|
|
| Completed | 1/2 | 86 | US | Paclitaxel, Carboplatin, STA 4783 | Synta Pharmaceuticals Corp. | Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer | | 03/05 | | |
